JP2021525059A5 - - Google Patents
Info
- Publication number
- JP2021525059A5 JP2021525059A5 JP2020558493A JP2020558493A JP2021525059A5 JP 2021525059 A5 JP2021525059 A5 JP 2021525059A5 JP 2020558493 A JP2020558493 A JP 2020558493A JP 2020558493 A JP2020558493 A JP 2020558493A JP 2021525059 A5 JP2021525059 A5 JP 2021525059A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- seq
- isolated antibody
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024014317A JP7798931B2 (ja) | 2018-04-30 | 2024-02-01 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
| JP2025281032A JP2026076162A (ja) | 2018-04-30 | 2025-12-24 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862664882P | 2018-04-30 | 2018-04-30 | |
| US62/664,882 | 2018-04-30 | ||
| PCT/IB2019/000503 WO2019211665A1 (en) | 2018-04-30 | 2019-04-29 | Cannabinoid receptor type 1 (cb1) binding proteins and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014317A Division JP7798931B2 (ja) | 2018-04-30 | 2024-02-01 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525059A JP2021525059A (ja) | 2021-09-24 |
| JP2021525059A5 true JP2021525059A5 (cg-RX-API-DMAC7.html) | 2022-05-11 |
| JP7431750B2 JP7431750B2 (ja) | 2024-02-15 |
Family
ID=67396963
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020558493A Active JP7431750B2 (ja) | 2018-04-30 | 2019-04-29 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
| JP2024014317A Active JP7798931B2 (ja) | 2018-04-30 | 2024-02-01 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
| JP2025281032A Pending JP2026076162A (ja) | 2018-04-30 | 2025-12-24 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014317A Active JP7798931B2 (ja) | 2018-04-30 | 2024-02-01 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
| JP2025281032A Pending JP2026076162A (ja) | 2018-04-30 | 2025-12-24 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
Country Status (21)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7431750B2 (ja) | 2018-04-30 | 2024-02-15 | 武田薬品工業株式会社 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
| AU2023249518A1 (en) * | 2022-04-04 | 2024-10-17 | Bird Rock Bio Sub, Inc. | Prediction and treatment of fast progressing renal disease |
| EP4534672A1 (en) | 2022-06-03 | 2025-04-09 | Shionogi & Co., Ltd | Antibody that binds to cannabinoid type 1 receptors |
| EP4539845A1 (en) * | 2022-06-17 | 2025-04-23 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Peripheralization of centrally-acting cannabinoid-1 receptor antagonists by nanoparticles for the treatment metabolic related conditions |
| WO2024022478A1 (zh) * | 2022-07-28 | 2024-02-01 | 长春金赛药业有限责任公司 | 结合大麻素受体cb1的抗体及其用途 |
| WO2025257151A1 (en) * | 2024-06-10 | 2025-12-18 | Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical composition for treating ciliopathies |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4609546A (en) | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5006309A (en) | 1988-04-22 | 1991-04-09 | Abbott Laboratories | Immunoassay device with liquid transfer between wells by washing |
| US5089424A (en) | 1988-06-14 | 1992-02-18 | Abbott Laboratories | Method and apparatus for heterogeneous chemiluminescence assay |
| US5063081A (en) | 1988-11-14 | 1991-11-05 | I-Stat Corporation | Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor |
| CA2069530A1 (en) | 1991-06-03 | 1992-12-04 | Cass J. Grandone | Reagent pack for immunoassays |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| WO1993011794A1 (en) | 1991-12-13 | 1993-06-24 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| US6914128B1 (en) | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
| US7419821B2 (en) | 2002-03-05 | 2008-09-02 | I-Stat Corporation | Apparatus and methods for analyte measurement and immunoassay |
| US20040018577A1 (en) | 2002-07-29 | 2004-01-29 | Emerson Campbell John Lewis | Multiple hybrid immunoassay |
| WO2005023232A2 (en) | 2003-09-04 | 2005-03-17 | Affibody Ab | Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| US7723099B2 (en) | 2003-09-10 | 2010-05-25 | Abbott Point Of Care Inc. | Immunoassay device with immuno-reference electrode |
| US7682833B2 (en) | 2003-09-10 | 2010-03-23 | Abbott Point Of Care Inc. | Immunoassay device with improved sample closure |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| EP2297209A4 (en) | 2008-06-03 | 2012-08-01 | Abbott Lab | IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF |
| CA2915386A1 (en) * | 2013-06-26 | 2014-12-31 | Amgen Inc. | Cb1 receptor antigen-binding proteins and uses thereof |
| KR102731863B1 (ko) | 2014-03-27 | 2024-11-19 | 버드 락 바이오, 인크. | 인간 카나비노이드 1(cb1) 수용체 결합 항체 |
| US10277406B1 (en) * | 2014-09-05 | 2019-04-30 | Digicert, Inc. | Authentication process for issuing sequence of short-lived digital certificates |
| US10034865B2 (en) | 2015-09-10 | 2018-07-31 | Kashiv Pharma, Llc | Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof |
| CA3000167A1 (en) * | 2015-09-30 | 2017-04-06 | Bird Rock Bio, Inc. | Antibodies that bind human cannabinoid 1 (cb1) receptor |
| EP3490542A4 (en) | 2016-07-26 | 2020-07-08 | Flagship Pioneering Innovations V, Inc. | NEUROMODULATION COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATION OF AN ANTI-CANCER RESPONSE |
| JP7431750B2 (ja) | 2018-04-30 | 2024-02-15 | 武田薬品工業株式会社 | カンナビノイド受容体1型(cb1)結合性タンパク質及びその使用 |
-
2019
- 2019-04-29 JP JP2020558493A patent/JP7431750B2/ja active Active
- 2019-04-29 IL IL278276A patent/IL278276B2/en unknown
- 2019-04-29 US US17/052,048 patent/US12202901B2/en active Active
- 2019-04-29 EP EP19742647.1A patent/EP3787746A1/en active Pending
- 2019-04-29 MX MX2020011498A patent/MX2020011498A/es unknown
- 2019-04-29 WO PCT/IB2019/000503 patent/WO2019211665A1/en not_active Ceased
- 2019-04-29 PE PE2020001750A patent/PE20210419A1/es unknown
- 2019-04-29 CA CA3098416A patent/CA3098416A1/en active Pending
- 2019-04-29 AU AU2019264029A patent/AU2019264029B2/en active Active
- 2019-04-29 EA EA202092593A patent/EA202092593A1/ru unknown
- 2019-04-29 MA MA052504A patent/MA52504A/fr unknown
- 2019-04-29 KR KR1020207032056A patent/KR102992188B1/ko active Active
- 2019-04-29 SG SG11202010388SA patent/SG11202010388SA/en unknown
- 2019-04-29 AR ARP190101123A patent/AR114436A1/es unknown
- 2019-04-29 CN CN201980029451.9A patent/CN112218684A/zh active Pending
- 2019-04-29 BR BR112020022035-3A patent/BR112020022035A2/pt unknown
- 2019-04-30 TW TW108115125A patent/TWI882957B/zh active
-
2020
- 2020-10-27 CL CL2020002793A patent/CL2020002793A1/es unknown
- 2020-10-29 PH PH12020551805A patent/PH12020551805A1/en unknown
- 2020-11-26 CO CONC2020/0014681A patent/CO2020014681A2/es unknown
- 2020-11-27 EC ECSENADI202076576A patent/ECSP20076576A/es unknown
-
2021
- 2021-03-16 US US17/203,291 patent/US11746155B2/en active Active
-
2024
- 2024-02-01 JP JP2024014317A patent/JP7798931B2/ja active Active
-
2025
- 2025-01-14 US US19/019,913 patent/US20250250341A1/en active Pending
- 2025-12-24 JP JP2025281032A patent/JP2026076162A/ja active Pending